on the negative side * increased competition in key US and European markets from US rivals with low cost product.* do they have currency hedging in place
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025